Spyre Therapeutics, Inc. (SYRE)
NASDAQ·Healthcare·Biotechnology
$86.95
+4.24%
Mkt Cap $4.88B
Analyst Ratings
Buy
18
Hold
0
Sell
0
Price Target (15 analysts)
$81.90
Range $49.00 – $106.00
Implied Upside
-5.8%
Consensus $81.90 vs current $86.95
NASDAQ·Healthcare·Biotechnology
$86.95
+4.24%
Mkt Cap $4.88B
Buy
18
Hold
0
Sell
0
Price Target (15 analysts)
$81.90
Range $49.00 – $106.00
-5.8%
Consensus $81.90 vs current $86.95